http://www.g1therapeutics.com
G1 Therapeutics, Inc. Company Intro
G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer.
Industry
Healthcare
G1 Therapeutics, Inc. Headquaters
700 Park Offices Drive
Research Triangle Park,27709
United States
G1 Therapeutics, Inc. Share price
17 May 2023 13:17 GMT
$2.8800
-0.04 (-1.37 %)
G1 Therapeutics, Inc. Market cap
$140 M
WMC RANKING
2024
G1 Therapeutics, Inc. # 105
BiotechnologyLatest G1 Therapeutics, Inc. News
12 Feb 2024
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following ...
RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced...
12 Feb 2024
G1 Therapeutics falls as cancer treatment fails to meet late-stage study goal
... ** Shares of drug maker G1 Therapeutics GTHX.O fall 36.6% to $2.86 in extended trade. ** Co says it will continue a late-stage trial on its experimental...
12 Feb 2024
G1 Therapeutics stock dives 36% post-market on P3 study update (NASDAQ:GTHX)
Shares of G1 Therapeutics (GTHX) plunged 36% in post-market trading after the company said the independent data monitoring committee overseeing a pivotal...
WMC Market Score
WMC Market to Revenue Score
G1 Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| G1 Therapeutics, Inc. | USD | $59,503 | $149,450 | $-94,673 | $1,400M | 105 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total G1 Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Post vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
G1 Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| G1 Therapeutics, Inc. | 0.65 | 3.79 | 0.02 | 0 | 0 | 0 | 1.36 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
